Calcium blockers for heart disease: two approved, more to come.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000787:Angina Pectoris / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D004110:Diltiazem / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D009543:Nifedipine / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine